You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

HPV vaccination

Showing 4676 - 4697 of 4,697
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

HIV Trial in Barcelona (Hepatitis A, Hepatitis B, Influenza)

Completed
  • HIV
  • Hepatitis A
  • +6 more
  • Barcelona, Spain
    Department of Infectious Diseases, Hospital Clínic, C/Villarroel
May 22, 2006

Tuberculosis, Latent Tuberculosis, Tuberculosis Contact Trial in Taichung (tuberculin for skin test)

Unknown status
  • Tuberculosis
  • +3 more
  • tuberculin for skin test
  • Taichung, Taiwan, China
    Division of Chest Medicine, Department of Internal Medicine, Tai
Apr 3, 2006

WT1 Expressing Carcinoma Trial in Berlin (WT1 126-134 peptide)

Unknown status
  • WT1 Expressing Carcinoma
  • WT1 126-134 peptide
  • Berlin, Germany
    Hem&Onc Charité CBF
Feb 13, 2006

Acute Myeloid Leukemia, Myelodysplastic Syndrome Trial in Berlin (WT1 126-134 peptide)

Unknown status
  • Acute Myeloid Leukemia
  • Myelodysplastic Syndrome
  • WT1 126-134 peptide
  • Berlin, Germany
    Hematology&Oncology Charité CBF
Feb 21, 2006

Cervical Cancer Trial in Taipei (HPV16 E7 peptide-pulsed autologous DCs)

Unknown status
  • Cervical Cancer
  • HPV16 E7 peptide-pulsed autologous DCs
  • Taipei, Taiwan
    National Taiwan University Hospital
Dec 19, 2005

The Development of Human Papillomavirus Type 16 E7-Specific

Unknown status
  • Cervical Cancer
    • Taipei, Taiwan
      National Taiwan University Hospital
    Dec 19, 2005

    Meningococcal Disease; Meningococcal Meningitis Trial in Oxford (· Meningococcal C conjugate vaccine; Meningococcal A/C

    Unknown status
    • Meningococcal Disease; Meningococcal Meningitis
    • · Meningococcal C conjugate vaccine; Meningococcal A/C Polysaccharide vaccine (partial dose)
    • Oxford, United Kingdom
      University of Oxford, The Oxford Vaccine Group
    Dec 2, 2005

    Immunity, Cellular, Hypersensitivity, Delayed Type Trial in Chilumba, Ilford (BCG)

    Completed
    • Immunity, Cellular
    • Hypersensitivity, Delayed Type
    • BCG
    • Chilumba, Karonga District, Malawi
    • +1 more
    Dec 14, 2005

    Level of Immunity Against Poliovirus Infection Trial (Inactivated Polio Vaccine given at an accelerated schedule)

    Completed
    • Level of Immunity Against Poliovirus Infection
    • Inactivated Polio Vaccine given at an accelerated schedule
    • (no location specified)
    Nov 29, 2005

    Pneumococcal Disease Prevention Trial in Atlanta (phone call from nurses - informational only)

    Completed
    • Pneumococcal Disease Prevention
    • phone call from nurses - informational only
    • Atlanta, Georgia
      Kaiser Permanente
    Sep 28, 2005

    Chronic Hepatitis B Trial (interferon alpha 2b plus ribavirin, interferon alpha 2b plus )

    Completed
    • Chronic Hepatitis B
    • interferon alpha 2b plus ribavirin
    • interferon alpha 2b plus placebo
    • (no location specified)
    Jan 11, 2006

    Hepatitis B, Liver Tumors, Liver Diseases Trial in Qidong, Beijing, Oxford (Hep-V Vax)

    Completed
    • Hepatitis B
    • +2 more
    • Hep-V Vax
    • Qidong, Jiangsu, China
    • +2 more
    Sep 13, 2005

    Anticoagulants, Influenza Vaccines Trial in Perugia (Influenza vaccination)

    Completed
    • Anticoagulants
    • Influenza Vaccines
    • Influenza vaccination
    • Perugia, Italy
      University of Perugia
    Sep 13, 2005

    Tuberculosis Trial in Cape Town (Japanese (Tokyo) 172 Bacille Calmette Guerin (BCG).)

    Unknown status
    • Tuberculosis
    • Japanese (Tokyo) 172 Bacille Calmette Guerin (BCG).
    • Cape Town, Western Cape, South Africa
      South African Tuberculosis Vaccine Initiative, Institute of Infe
    Oct 18, 2005

    Hepatitis B, Vaccine Trial in Taipei (Hepatitis B vaccine)

    Unknown status
    • Hepatitis B
    • Vaccine
    • Hepatitis B vaccine
    • Taipei, Taiwan
      National Taiwan University Hospital
    Sep 12, 2005

    Melanoma Trial in Lausanne (Melan-A analog peptide)

    Suspended
    • Melanoma
    • Melan-A analog peptide
    • Lausanne, Switzerland
      Multidisciplinary Oncology Center, University of Lausanne Hospit
    Sep 8, 2005

    Treatment of Verruca Vulgaris

    Unknown status
    • Warts
      • Taipei, Taiwan
        National Taiwan University Hospital
      Sep 9, 2005

      Prostate Cancer Trial (Immunotherapy allogeneic GM-CSF secreting cellular vaccine)

      Completed
      • Prostate Cancer
      • Immunotherapy allogeneic GM-CSF secreting cellular vaccine
      • (no location specified)
      Aug 30, 2005

      HIV Trial in New York (Thalidomide)

      Completed
      • HIV Infections
      • New York, New York
        Aaron Diamond AIDS Rsch Ctr / Rockefeller Univ
      Jun 23, 2005

      Human Immunodeficiency Virus Type 1 in Vaginocervical

      Completed
      • HIV Infections
        • San Francisco, California
        • +2 more
        Jun 23, 2005

        Leukemia,Myeloid, Chronic, Leukemia,Myeloid,Philadelphia-Positive Trial in Farmington (Heat Shock Protein 70 HSP70)

        Completed
        • Leukemia,Myeloid, Chronic
        • Leukemia,Myeloid,Philadelphia-Positive
        • Heat Shock Protein 70 HSP70
        • Farmington, Connecticut
          University of Connecticut Health Center
        Jun 23, 2005

        Lymphoma, Non-Hodgkin Trial in Ann Arbor (tumor-pulsed dendritic cells)

        Completed
        • Lymphoma, Non-Hodgkin
        • tumor-pulsed dendritic cells
        • Ann Arbor, Michigan
          University of Michigan Medical Center
        Jun 23, 2005